Found: 3 articles

Article Edition
Orlova-Morozova E.A., Pronin A.Yu.
The use of doravirine as part of antiretroviral therapy regimens in patients with resistance mutations
№3 / 2021
Kravchenko A.V., Orlova-Morozova E.A., Shimonova T.E., Kozyrev O.A., Nagimova F.I., Zakharova N.G., Ivanova E.S., Sonin D.B., Chernova O.E., Tonkikh O.S., Yakovlev A.A., Kurina N.V., Pokrovsky V.V., Bychko V.V., Vostokova N.V., Zozulya O.V.
The efficacy and safety of Elpivirine as part of a 24-48-week antiretroviral therapy regimen versus an Efavirenz-containing regimen
№5 / 2016
Sizova N.V., Volova L.Yu., Malyuzhenko I.V., Isaeva G.N., Koveleno A.Yu., Minaeva S.V., Topolskaya S.V., Voronin E.E., Okhonskaya L.V.
The first results of using the combined drug rilpivirine/tenofovir/emtricitabine in Russian patients with HIV infection in real clinical practice
№6 / 2015


Бионика Медиа